HealthJohnson & Johnson is '71% Effective' Against Delta Variant, According to Recent Trial in South Africa The clinical trial in South Africa revealed that the Johnson & Johnson vaccine can combat the Delta variant at 71% effectivity.by Joseph Henry
HealthCOVID-19 Misinformation Also Lurks in Doximity: Doctors Claim Even Fellow Physicians Spread Fake Newsby Griffin Davis
Health'Monoclonal Antibody Treatment' Helps Reduce Severe Risks of COVID-19, But Why is the FDA Reserving it to Specific People?by Isaiah Richard
HealthControversial Aduhelm Alzheimer Drug's Quick Approval To Be Reviewed: US HHS Now Questions FDA's Decisionby Griffin Davis
HealthFacebook Blocks COVID-19 Misinformation Researchers from NYU, Cuts off Access to Ad Libraryby Isabella James
Health#Techtimeslifehack: Reasons Why Unvaccinated People Should Get COVID-19 Vaccinesby Griffin Davis
HealthCOVID-19: University of Pittsburgh Researchers Develop Single-Domain Antibody For SARS-COV-2 Variantsby Joseph Henry
HealthThis U.S. State Has the Worst COVID-19 Hospitalization Rate Among Kids, Teens — Can You Guess Where?by Isabella James
HealthUNC Students 'Knew How to Buy Fake Vaccine Cards' to Comply with University Shot Requirementby Urian B.
HealthCOVID-19: Unvaccinated Vs. Vaccinated; New X-Ray Images Reveal Alarming Lung Differences in Oxygen Inhalationby Griffin Davis
HealthRansomware Attacks COVID-19 Vaccination Registration System in Italy, Appointment Booking Blockedby Teejay Boris
HealthMobile Health Clinics Bridge Gap to Underprivileged Communities, Bridging Comms with iPad Translatorsby Isaiah Richard
Waymo Robotaxis Hit London Streets as Driverless Cars Prepare to Challenge Uber, Transform Urban Travel